4MU-16123-73228
2 vaccinations
1 coded response
23 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 781 / TX
- Registered
- 2021-09-28
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-28
Registered in v-safe
-
2021-09-28
Dose 1 — Pfizer-BioNTech
- 2021-09-28
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-12
-
2021-10-19
Dose 2 — Pfizer-BioNTech
- 2021-10-19
- 2021-10-20
-
2021-10-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-22
- 2021-10-23
-
2021-10-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-25
- 2021-10-26
- 2021-11-02
-
2021-11-09
Survey response — day 21, dose 2MedDRA: Headache — Feeling: Poor · Be unable to do your normal daily activitiesFree text: HeadachesMedDRA releases: 2024-11 · check-in free text available
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2022-01-18
- 2022-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-28 | Pfizer-BioNTech | No |
| 2 | 2021-10-19 | Pfizer-BioNTech | No |
Free text
Release 10 — day 21, dose 2
Symptoms: Headaches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release